Work

Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression

Year: 2013

Type: article

Source: Brain Behavior and Immunity

DOI: 10.1016/j.bbi.2013.04.004

Authors: Divya Mehta, Charles L. Raison, Bobbi J. Woolwine, Ebrahim Haroon, Elisabeth B. Binder, Andrew H. Miller, Jennifer C. Felger

Institutions: Max Planck Institute of Psychiatry, University of Arizona, Emory University

Language: English

Topic: Tryptophan and brain disorders

Subfield: Biological Psychiatry

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Mental Health, National Cancer Institute, National Center for Research Resources, National Center for Advancing Translational Sciences

Awards: Atlanta Clinical and Translational Science Institute (UL1), Neurobiological and Behavioral Effects of Cytokine Antagonism in Major Depression, G2344886790, Predictors and Targets of Response to Cytokine Antagonism in Depression, Dynamics of Inflammation and its Blockade on Motivational Circuitry in Depression, Inflammation Effects on Corticostriatal Connectivity and Reward: Role of Dopamine, Phenotyping Major Depression with Increased Inflammation, Atlanta Clinical and Translational Science Institute (ACTSI) Renewal, GENERAL CLINICAL RESEARCH CENTER, G680909297, Winship Cancer Institute Cancer Center Support Grant, Georgia Clinical & Translational Science Alliance (Georgia CTSA)

OpenAlex ID: W2054093295

FWCI: 2.696

Cites: 74

Cited by: 74

Related to: 10